Literature DB >> 20156095

Evaluation of HIV type 1 strains in men having sex with men and in female sex workers in Mombasa, Kenya.

Sodsai Tovanabutra1, Eduard J Sanders, Susan M Graham, Mary Mwangome, Norbert Peshu, R Scott McClelland, Allan Muhaari, Jacqueline Crossler, Matt A Price, Jill Gilmour, Nelson L Michael, Francine M McCutchan.   

Abstract

We compared HIV-1 strains in incident and prevalent infections in a cohort of men having sex with men (MSM) and female sex workers (FSW) near Mombasa, Kenya and conducted a cross-sectional study of viral isolates from a sample of HIV-1-infected MSM and FSW in Kilifi, Coast Province, Kenya. RNA extracted from plasma of 13 MSM, 9 FSW, and one heterosexual male was amplified by nested RT-PCR and the products were directly sequenced. HIV-1 strains from 21 individuals were characterized with one or more complete genome sequences, and two were sequenced in the Nef gene. The envelope quasispecies was also studied in one individual. Among MSM, eight strains were subtype A and five were recombinant. There were two epidemiologically linked pairs of sequences; one pair was subtype A and the other pair was a complex AA2CD recombinant of identical structure. Another MSM was dually infected with DG recombinant strains of related, but nonidentical, structure. MSM also harbored AC and AD recombinant strains. The FSW harbored seven subtype A strains, an AD recombinant, and an AA2D strain related to CRF16_A2D. The one heterosexual male studied had a subtype A infection. This MSM epidemic in Kenya appears to be of local origin, harboring many strains typical of the broader Kenyan epidemic. Characteristics of a close social network were identified, with extended chains of transmission, novel recombinant strains possibly generated within the network, and a relatively high proportion of recombinant and dual infections.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20156095     DOI: 10.1089/aid.2009.0115

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  17 in total

1.  RecDraw: a software package for the representation of HIV-1 recombinant structures.

Authors:  Gustavo H Kijak; Sodsai Tovanabutra; Chris Beyrer; Eric E Sanders-Buell; Miguel A Arroyo; Merlin L Robb; Nelson L Michael; Francine E McCutchan; Jerome H Kim
Journal:  AIDS Res Hum Retroviruses       Date:  2010-10-21       Impact factor: 2.205

2.  Molecular evolution of the HIV-1 Thai epidemic between the time of RV144 immunogen selection to the execution of the vaccine efficacy trial.

Authors:  Gustavo H Kijak; Sodsai Tovanabutra; Supachai Rerks-Ngarm; Sorachai Nitayaphan; Chirapa Eamsila; Prayura Kunasol; Chirasak Khamboonruang; Prasert Thongcharoen; Chawetsan Namwat; Nakorn Premsri; Michael Benenson; Patricia Morgan; Meera Bose; Eric Sanders-Buell; Robert Paris; Merlin L Robb; Deborah L Birx; Mark S De Souza; Francine E McCutchan; Nelson L Michael; Jerome H Kim
Journal:  J Virol       Date:  2013-04-10       Impact factor: 5.103

3.  Older age at infection and nulliparity are associated with long-term non-progression in female sex workers infected with non-subtype B HIV-1.

Authors:  Vernon Mochache; Barbra A Richardson; Linnet N Masese; Susan M Graham; Kishorchandra Mandaliya; John Kinuthia; Walter Jaoko; Julie Overbaugh; R Scott McClelland
Journal:  Int J STD AIDS       Date:  2020-04-15       Impact factor: 1.359

Review 4.  Does HIV Exploit the Inflammatory Milieu of the Male Genital Tract for Successful Infection?

Authors:  Rachel T Esra; Abraham J Olivier; Jo-Ann S Passmore; Heather B Jaspan; Rushil Harryparsad; Clive M Gray
Journal:  Front Immunol       Date:  2016-06-24       Impact factor: 7.561

5.  High HIV-1 incidence, correlates of HIV-1 acquisition, and high viral loads following seroconversion among MSM.

Authors:  Eduard J Sanders; Haile S Okuku; Adrian D Smith; Mary Mwangome; Elizabeth Wahome; Gregory Fegan; Norbert Peshu; Elisabeth M van der Elst; Matthew A Price; R Scott McClelland; Susan M Graham
Journal:  AIDS       Date:  2013-01-28       Impact factor: 4.177

Review 6.  Phylogenetic studies of transmission dynamics in generalized HIV epidemics: an essential tool where the burden is greatest?

Authors:  Ann M Dennis; Joshua T Herbeck; Andrew L Brown; Paul Kellam; Tulio de Oliveira; Deenan Pillay; Christophe Fraser; Myron S Cohen
Journal:  J Acquir Immune Defic Syndr       Date:  2014-10-01       Impact factor: 3.731

7.  HIV Type 1 transmission networks among men having sex with men and heterosexuals in Kenya.

Authors:  Daniela Bezemer; Nuno Rodrigues Faria; Amin Hassan; Raph L Hamers; Gaudensia Mutua; Omu Anzala; Kishor Mandaliya; Patricia Cane; James A Berkley; Tobias F Rinke de Wit; Carole Wallis; Susan M Graham; Matthew A Price; Roel A Coutinho; Eduard J Sanders
Journal:  AIDS Res Hum Retroviruses       Date:  2013-09-17       Impact factor: 2.205

8.  HIV type 1 in a rural coastal town in Kenya shows multiple introductions with many subtypes and much recombination.

Authors:  Stéphane Hué; Amin S Hassan; Helen Nabwera; Eduard J Sanders; Deenan Pillay; James A Berkley; Patricia A Cane
Journal:  AIDS Res Hum Retroviruses       Date:  2011-07-19       Impact factor: 2.205

9.  HIV-1 subtypes and recombinants in Northern Tanzania: distribution of viral quasispecies.

Authors:  Ireen E Kiwelu; Vladimir Novitsky; Lauren Margolin; Jeannie Baca; Rachel Manongi; Noel Sam; John Shao; Mary F McLane; Saidi H Kapiga; M Essex
Journal:  PLoS One       Date:  2012-10-31       Impact factor: 3.240

10.  The Number and Complexity of Pure and Recombinant HIV-1 Strains Observed within Incident Infections during the HIV and Malaria Cohort Study Conducted in Kericho, Kenya, from 2003 to 2006.

Authors:  Erik Billings; Eric Sanders-Buell; Meera Bose; Andrea Bradfield; Esther Lei; Gustavo H Kijak; Miguel A Arroyo; Rukia M Kibaya; Paul T Scott; Monique K Wasunna; Frederick K Sawe; Douglas N Shaffer; Deborah L Birx; Francine E McCutchan; Nelson L Michael; Merlin L Robb; Jerome H Kim; Sodsai Tovanabutra
Journal:  PLoS One       Date:  2015-08-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.